DAVID WILLIAMS, OD
Optometry at Montgomery Rd, Cincinnati, OH
License number
Ohio 6328T3244
Category
Optometry
Type
Optometrist
Address
Address
2
7710 Montgomery Rd STE A, Cincinnati, OH 45236
140 Macomb Pl, Mount Clemens, MI 48043
140 Macomb Pl, Mount Clemens, MI 48043
Phone
(513) 791-5911
(513) 791-6771 (Fax)
(586) 468-7370
(586) 464-1480 (Fax)
(513) 791-6771 (Fax)
(586) 468-7370
(586) 464-1480 (Fax)
Personal information
See more information about DAVID WILLIAMS at radaris.comName
Address
Phone
17921 Dudley Cemetary Ln, Caldwell, OH 43724
1785 Scully Rd, Mount Pleasant, MI 48858
1800 Pine St, Birmingham, MI 48009
1801 Nemoke Ct Apt 8, Haslett, MI 48840
1758 S Arlington St, Akron, OH 44306
Organization information
See more information about DAVID WILLIAMS at bizstanding.comDavid Williams MD
830 Ezzard Charles Dr, Cincinnati, OH 45214
Industry:
Internist
Phone:
(513) 381-6672 (Phone)
David Symmes Williams
Professional information
Owner At Williams Jewelers, Incorporated
Position:
Owner at JDW Wyoming Propeties, LLC, Owner at Williams Jewelers, Incorporated
Location:
Cincinnati Area
Industry:
Retail
Work:
JDW Wyoming Propeties, LLC
since Mar 2005
-
Owner
Williams Jewelers, Incorporated
since Apr 1992
-
Owner
Education:
The Ohio State University 1985 - 1990
Bachelor of Science, Hospitality Management Gemological Institute of America
Bachelor of Science, Hospitality Management Gemological Institute of America
David Williams
Location:
Cincinnati Area
Industry:
Information Technology and Services
Consumer Electronics Professional
Location:
Cincinnati Area
Industry:
Consumer Electronics
Dr. David S Williams, Cincinnati OH - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
311 Straight St, Cincinnati 45219
(513) 559-2236 (Phone), (513) 475-5252 (Fax)
(513) 559-2236 (Phone), (513) 475-5252 (Fax)
Certifications:
Internal Medicine, 1982
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of Cincinnati / Main Campus
Graduated: 1979
Christ Hospital
University of Cincinnati / Main Campus
Graduated: 1979
Christ Hospital
Photographer At Waxing Gibbous Photography
Position:
Photographer at Waxing Gibbous Photography
Location:
Cincinnati Area
Industry:
Photography
Work:
Waxing Gibbous Photography
-
Photographer
Skills:
Portrait Photography
David Williams
Location:
Cincinnati Area
Industry:
Banking
Skills:
Information Security Management, Banking, Risk Management
Mobilization Of Hematopoietic Cells
US Patent:
7417026, Aug 26, 2008
Filed:
Aug 12, 2004
Appl. No.:
10/918328
Inventors:
David A. Williams - Cincinnati OH, US
Yi Zheng - Cincinnati OH, US
Yi Zheng - Cincinnati OH, US
Assignee:
Children's Hospital Medical Center - Cincinnati OH
International Classification:
A61K 38/00
US Classification:
514 12
Abstract:
Improved methods and pharmaceutical compositions are provided herein for mobilizing hematopoietic progenitor cells from bone marrow into peripheral blood, comprising the administration of an effective amount of an inhibitor of GTPases, such as Rac1 and Rac2 alone or in combination. Specifically, methods are disclosed for mobilizing hematopoietic stem cells into a subject's peripheral blood. In particular, embodiments of the method involve inhibition of both Rac1 and Rac2 GTPases to increase the numbers of hematopoietic stem cells into a subject's peripheral blood of a subject. The subject's blood can be processed and used to repopulate the destroyed lymphohematopoietic system of a recipient and may in the future be utilized to repair a variety of non-hematopoietic tissues. Therefore, hematopoietic stem cells mobilized into a subject's peripheral blood by the method of the invention is useful as a source of donor cells in bone marrow transplantation for the treatment of a variety of disorders, including cancer, anemia, autoimmunity and immunodeficiency. They can also be used for increasing white blood cell survival and for chemotherapy.
Chimeric Peptides For The Regulation Of Gtpases
US Patent:
7915384, Mar 29, 2011
Filed:
Jan 5, 2009
Appl. No.:
12/348762
Inventors:
Yi Zheng - Cincinnati OH, US
David A. Williams - Cincinnati OH, US
David A. Williams - Cincinnati OH, US
Assignee:
Children's Hospital Medical Center - Cincinnati OH
International Classification:
C07K 14/00, A01N 37/18
US Classification:
530350, 514 2
Abstract:
Chimeric peptides or fusion proteins are disclosed that include a RhoGAP activity domain and at least one specificity domain that targets a specific Rho protein. The fusion proteins can be used to inhibit any GTPase activity within a cell. The fusion proteins are particularly advantageous for the treatment of cancer. The present invention generally relates to chimeric peptides capable of regulating GTPases, and more particularly, to methods of targeting individual GTPases by using GTPase-activating proteins. Such proteins may be used for the treatment of cancers and other GTPase-related diseases. This invention relates to nucleic acid molecules and the encoded GTPase activating proteins, and variants thereof, and to the use of these molecules in the characterization, diagnosis, prevention, and treatment of cell signaling, immune, and cell proliferative disorders, particularly cancer. Disclosed herein are compounds and methods for regulating transcription of a selected gene.
Clinical Development Plan, Facility Development Plan And Process Development Plan Knowledge Bases
US Patent:
2006017, Aug 10, 2006
Filed:
Jan 13, 2005
Appl. No.:
11/035019
Inventors:
Christof Kalle - Cincinnati OH, US
Lilith Reeves - Avon IN, US
David Williams - Cincinnati OH, US
Lilith Reeves - Avon IN, US
David Williams - Cincinnati OH, US
International Classification:
G06Q 99/00
US Classification:
705002000, 705001000
Abstract:
Exemplary embodiments of the present invention provide three knowledge bases: (1) a clinical development plan (CDP) knowledge base for development of a molecular or cellular Phase I or II clinical trial; (2) a facility development plan (FDP) knowledge base for the economic and functional setup of translational laboratory, clean room production and cell handling facilities including the processes of planning, constructing and validating a facility for GCP testing and GMP manufacturing of products to support molecular and gene therapy clinical trials; and (3) a process development plan (PDP) knowledge base for development of manufacturing and analytic processes in support of Phase I or II clinical trials. The present invention also provides systems and methods associated with such knowledge bases.
Gtpase Inhibitors And Use Thereof For Controlling Platelet Hyperactivity
US Patent:
7612080, Nov 3, 2009
Filed:
Nov 18, 2005
Appl. No.:
11/283556
Inventors:
Yi Zheng - Cincinnati OH, US
Huzoor Akbar - Athens OH, US
David A. Williams - Cincinnati OH, US
Wieslaw Adam Mazur - Mason OH, US
Huzoor Akbar - Athens OH, US
David A. Williams - Cincinnati OH, US
Wieslaw Adam Mazur - Mason OH, US
Assignee:
Cincinnati Children's Hospital Medical Center - Cincinnati OH
International Classification:
A61K 31/506
US Classification:
514275
Abstract:
The preferred embodiments generally relate to methods and compositions that affect the GTP-binding activity of members of the Rho family GTPases, preferably Rac (Rac1, Rac2 and/or Rac3), such compositions include compounds that modulate the GTP/GDP exchange activity, along with uses for the compounds including screening for compounds which recognize Rac GTPase, and methods of treating pathological conditions associated or related to a Rho family GTPase, including Rac. The preferred embodiments also relate to methods of using such compounds, or derivatives thereof, e. g. , in therapeutics, diagnostics, and as research tools.